Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets and Plasma-Lyte 56
Determining the interaction of Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets and Plasma-Lyte 56 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dasabuvir / ombitasvir / paritaprevir / ritonavir
Brand name: Viekira XR, Viekira Pak
Synonyms: Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets, and Dasabuvir
Generic Name: lvp solution with potassium
Brand name:
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Plasma-Lyte 56 and Dextrose
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Platinol
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Platinol-AQ
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Plavix
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Plazomicin
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Plazomicin Intravenous
- Plasma-Lyte 56-Omeclamox-Pak
- Plasma-Lyte 56-Omega-3 Fatty Acid Capsules
- Plasma-Lyte 56-Omega-3 Fatty Acids
- Plasma-Lyte 56-Omega-3 polyunsaturated fatty acids
- Plasma-Lyte 56-Omega-3-acid ethyl esters
- Plasma-Lyte 56-Omega-3-carboxylic acids